Assessment of C-Reactive Protein, Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients at Different Stages of Chronic Kidney Disease

1 Mihai S, Codrici E, Popescu ID, et al. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome. J Immunol Res. 2018;2018:2180373.10.1155/2018/2180373614677530271792 Search in Google Scholar

2 Dungey M, Hull KL, Smith AC, Burton JO, Bishop NC. Inflammatory factors and exercise in chronic kidney disease. Int J Endocrinol. 2013;2013:569831.10.1155/2013/569831366622823737775 Search in Google Scholar

3 Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84-92.10.1159/00036894025662331 Search in Google Scholar

4 Neuen BL, Leather N, Greenwood AM, Gunnarsson R, Cho Y, Mantha ML. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2016;38:70-76.10.3109/0886022X.2015.110499026540580 Search in Google Scholar

5 Brito GMC, Fontenele AMM, Carneiro ECRL, et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients. Int J Inflam. 2021;2021:6678960.10.1155/2021/6678960824525434257898 Search in Google Scholar

6 Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189-1197.10.1093/ndt/16.6.118911390719 Search in Google Scholar

7 Yilmaz G, Sevinc C, Ustundag S, et al. The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease. Saudi J Kidney Dis Transpl. 2017;28:90-94.10.4103/1319-2442.19815228098108 Search in Google Scholar

8 Kamis F, Bakirdogen S, Burcu Cam A. The relationship between renal resistive index and simple hematologic indices in patients with chronic kidney disease. J Health Sci Med. 2021;4:45-48. Search in Google Scholar

9 Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-657.10.1016/j.amjcard.2008.05.00618773982 Search in Google Scholar

10 Uthamalingam S, Patvardhan EA, Subramanian S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107:433-438.10.1016/j.amjcard.2010.09.03921257011 Search in Google Scholar

11 Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105:186-191.10.1016/j.amjcard.2009.09.00720102916 Search in Google Scholar

12 Park JJ, Jang HJ, Oh IY, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111:636-642.10.1016/j.amjcard.2012.11.01223273716 Search in Google Scholar

13 Kocyigit I, Eroglu E, Unal A, et al. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26:358-365.10.5301/jn.500015222573523 Search in Google Scholar

14 Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016;85:199-208.10.5414/CN10858426521887 Search in Google Scholar

15 Sevencan NO, Ozkan AE. Associations between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, albuminuria and uric acid and the estimated glomerular filtration rate in hypertensive patients with chronic kidney disease stages 1-3. Arch Med Sci. 2019;15:1232-1239.10.5114/aoms.2018.76262676430631572468 Search in Google Scholar

16 Binnetoglu E, Sengul E, Halhalli S, Dindar S, Sen H. Is Neutrophil Lymphocite Ratio an Indicator for Proteinuria in Chronic Kidney Disease? J Clin Lab Anal. 2014;28:487-492.10.1002/jcla.21715680745224659410 Search in Google Scholar

17 Lee C, Park KH, Joo YS, et al. Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD. J Am Heart Assoc. 2020;9:e017980.10.1161/JAHA.120.017980776341533092438 Search in Google Scholar

18 Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237-245.10.1111/j.1523-1755.2005.00398.x15954913 Search in Google Scholar

19 Hung AM, Ikizler TA, Griffin MR, et al. CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey. BMC Med Genet. 2011;12:65.10.1186/1471-2350-12-65311917921569369 Search in Google Scholar

20 Fried L, Solomon C, Shlipak M, et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15:3184-191.10.1097/01.ASN.0000146422.45434.3515579522 Search in Google Scholar

21 Ichihara K, Tanaka T, Takahashi S, et al. Serum procalcitonin level in chronic hemodialytic patients with no evidence of bacterial infection. Ren Replace Ther. 2016;2:9.10.1186/s41100-016-0025-3 Search in Google Scholar

22 Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality. Perit Dial Int. 1999;19(S2):S309-14.10.1177/089686089901902S52 Search in Google Scholar

23 Liu C, Li H. Correlation of the severity of chronic kidney disease with serum inflammation, osteoporosis and vitamin D deficiency. Exp Ther Med. 2019;17:368-372. Search in Google Scholar

24 Tbahriti HF, Meknassi D, Moussaoui R, et al.Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines. World J Nephrol. 2013;2:31-37.10.5527/wjn.v2.i2.31378222224175263 Search in Google Scholar

25 Lavín-Gómez BA, Palomar-Fontanet R, Gago-Fraile M, et al. Inflammation markers, chronic kidney disease, and renal replacement therapy. Adv Perit Dial. 2011;27:33-37. Search in Google Scholar

26 Adejumo OA, Okaka EI, Okwuonu CG, Iyawe IO, Odujoko OO. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria. Ghana Med J. 2016;50:31-38.10.4314/gmj.v50i1.5499448027605722 Search in Google Scholar

27 Lalramenga PC, Gupta S, Naveen P. Study of C-Reactive Protein Significance in Chronic Kidney Disease. International Journal of Contemporary Medical Research. 2019;6:22-25.10.21276/ijcmr.2019.6.6.48 Search in Google Scholar

28 Pravin NB, Jayashree SB, Shilpa BA, Suhas SB, Anand PT. Study of serum uric acid and C-reactive protein levels in patients with chronic renal disease. Int J Biol Med Res. 2013;4:2758-2761. Search in Google Scholar

29 Abraham G, Sundaram V,Sundaram V, Matthew M, Leslie N, Sathiah V. C-reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl. 2009;20:811-815. Search in Google Scholar

30 Sharain K, Hoppensteadt D, Bansal V, Singh A, Fareed J. Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease. Clin Appl Thromb Hemost. 2013;19:303-308.10.1177/107602961245493522865783 Search in Google Scholar

31 Thaha M, Imroati TA, Wardana A, Widodo W, Pranawa P, Irwanadi C. Comparison of High-sensitivity C-reactive Protein Level between Chronic Kidney Disease Stages. Biomolecular And Health Science Journal. 2018;1:1-9.10.20473/bhsj.v1i1.8226 Search in Google Scholar

32 Gao J, Wang A, Li X, et al. The Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Chronic Kidney Diseases. Kidney Blood Press Res. 2020;45:84-94.10.1159/00050425131794962 Search in Google Scholar

33 Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3:957-976. Search in Google Scholar

34 Umeres-Francia GE, Rojas-Fernández MV, Herrera-Añazco P, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as risk factors for mortality in Peruvian adults with chronic kidney disease. Ren Replace Ther. 2020;8:30.10.1186/s41100-022-00420-9 Search in Google Scholar

35 Sawant AC, Adhikari P, Narra SR, Srivatsa SS, Mills PK, Srivatsa SS. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500-508.10.5603/CJ.a2013.014824142685 Search in Google Scholar

36 Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-657.10.1016/j.amjcard.2008.05.00618773982 Search in Google Scholar

37 Wan H, Wang Y, Fang S, et al. Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study. J Diabetes Res. 2020;2020:6219545.10.1155/2020/6219545720687532405503 Search in Google Scholar

38 Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 2010;105:186-191.10.1016/j.amjcard.2009.09.00720102916 Search in Google Scholar

39 Okyay GU, Inal S, Oneç K, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35:29-36.10.3109/0886022X.2012.73442923113674 Search in Google Scholar

40 Kocyigit I, Eroglu E, Unal A, et al. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26:358-365.10.5301/jn.500015222573523 Search in Google Scholar

41 Jaaban M, Zetoune AB, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7:e07564.10.1016/j.heliyon.2021.e07564832673034368476 Search in Google Scholar

42 Winter L, Wong LA, Jerums G, et al. Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease. Front Endocrinol (Lausanne). 2018;9:225.10.3389/fendo.2018.00225599240029910771 Search in Google Scholar

43 Sambel M, Kilic M, Demirbas M, et al. Relationship between erectile dysfunction and the neutrophil to lymphocyte and platelet to lymphocyte ratios. Int J Impot Res. 2018;30:27-35.10.1038/s41443-017-0007-129196693 Search in Google Scholar

44 Tola EN. The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples. Taiwan J Obstet Gynecol. 2018;57:289-294.10.1016/j.tjog.2018.02.01929673675 Search in Google Scholar

45 Fukuda H, Takagi T, Kondo T, Shimizu S, Tanabe K. Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy. Oncotarget. 2018;9:14296-14305.10.18632/oncotarget.24507586567029581844 Search in Google Scholar

46 Uzun F, Erturk M, Cakmak HA, et al. Usefulness of the platelet-tolymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej. 2017;13:32-38. Search in Google Scholar

47 Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015;15:640-647.10.5152/akd.2014.5565533686525550173 Search in Google Scholar

48 Corriere T, Di Marca S, Cataudella E, et al. Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. Nutr Metab Cardiovasc Dis. 2018;28:23-27.10.1016/j.numecd.2017.10.02229241668 Search in Google Scholar

49 Tatar E, Mirili C, Isikyakar T, et al. The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3-5 chronic kidney disease. Acta Clin Belg. 2016;71:221-226.10.1080/17843286.2016.115979727309205 Search in Google Scholar

50 Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013;17:391-396.10.1111/hdi.1204023522328 Search in Google Scholar